132 related articles for article (PubMed ID: 20798601)
1. CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene therapy.
Huang YH; Cozzitorto JA; Richards NG; Eltoukhy AA; Yeo CJ; Langer R; Anderson DG; Brody JR; Sawicki JA
Cancer Biol Ther; 2010 Nov; 10(9):878-84. PubMed ID: 20798601
[TBL] [Abstract][Full Text] [Related]
2. High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.
Hucl T; Brody JR; Gallmeier E; Iacobuzio-Donahue CA; Farrance IK; Kern SE
Cancer Res; 2007 Oct; 67(19):9055-65. PubMed ID: 17909009
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.
Ren YR; Patel K; Paun BC; Kern SE
J Biol Chem; 2011 Apr; 286(14):11960-9. PubMed ID: 21288909
[TBL] [Abstract][Full Text] [Related]
4. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene.
Mukhopadhyay K; Lefebvre V; Zhou G; Garofalo S; Kimura JH; de Crombrugghe B
J Biol Chem; 1995 Nov; 270(46):27711-9. PubMed ID: 7499238
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma.
Rothfels H; Paschen A; Schadendorf D
Exp Dermatol; 2003 Dec; 12(6):799-810. PubMed ID: 14714561
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG).
Kakar SS
Gene; 1999 Nov; 240(2):317-24. PubMed ID: 10580151
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
9. Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
Tanyi JL; Lapushin R; Eder A; Auersperg N; Tabassam FH; Roth JA; Gu J; Fang B; Mills GB; Wolf J
Gynecol Oncol; 2002 Jun; 85(3):451-8. PubMed ID: 12051873
[TBL] [Abstract][Full Text] [Related]
10. Gamma-globin gene promoter elements required for interaction with globin enhancers.
Langdon SD; Kaufman RE
Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
[TBL] [Abstract][Full Text] [Related]
11. Identification of an enhancer-like element in the polyhedrin gene upstream region of Bombyx mori nucleopolyhedrovirus.
Acharya A; Gopinathan KP
J Gen Virol; 2001 Nov; 82(Pt 11):2811-2819. PubMed ID: 11602794
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway.
Kitazono M; Chuman Y; Aikou T; Fojo T
Int J Cancer; 2002 May; 99(3):453-9. PubMed ID: 11992417
[TBL] [Abstract][Full Text] [Related]
13. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
Laurencikiene J; Deveikaite V; Severinson E
J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
[TBL] [Abstract][Full Text] [Related]
14. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
[TBL] [Abstract][Full Text] [Related]
15. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
Xu J; Capezzone M; Xu X; Hershman JM
Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
[TBL] [Abstract][Full Text] [Related]
16. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
Mertz JA; Mustafa F; Meyers S; Dudley JP
J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
18. Identification of basal promoter and enhancer elements in an untranslated region of the TT virus genome.
Suzuki T; Suzuki R; Li J; Hijikata M; Matsuda M; Li TC; Matsuura Y; Mishiro S; Miyamura T
J Virol; 2004 Oct; 78(19):10820-4. PubMed ID: 15367649
[TBL] [Abstract][Full Text] [Related]
19. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
20. Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.
Ren YR; Chaerkady R; Hu S; Wan J; Qian J; Zhu H; Pandey A; Kern SE
J Proteome Res; 2012 Nov; 11(11):5301-10. PubMed ID: 23025254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
